A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery: Possible usefulness of PF4-heparin ELISA test

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 7, 1996, Pages 665-671

  Elalamy, I ^a   Potevin, F ^a   Lecrubier, C ^a   Bara, L ^a   Marie, J P ^a   Samama, M M ^a  

^a HÔTEL DIEU   (France)

Author keywords

Heparin; Heparin associated thrombocytopenia; Low molecular weight heparin; PF4 heparin ELISA; Thrombocytopenia; Venous thrombosis

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ARTICLE; CASE REPORT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; HIP SURGERY; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0029849068     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199610000-00001     Document Type: Article

References (32)

1. Kapsch DN, Adestein EH, Rhodes GR, Silver D. Heparin-induced thrombocytopenia, thrombosis and haemorrhage. Surgery 1979; 86: 148-155.
2. Chong BH. Heparin-induced thrombocytopenia. Annotation. Br J Haematol 1995; 89: 431-439.
3. Warkentin TE, Kelton JG. Interaction of heparin with platelets, including heparin-induced thrombocytopenia. In: Bounameaux H, ed. Low Molecular Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases. Vol 19: Fundamental and clinical cardiology. New York: Marcel Dekker, 1994: 75-127.
4. Leroy J, Leclerc MH, Delahousse B, et al. Treatment of heparin-induced thrombocytopenia and thrombosis with low molecular weight heparin (CY216). Sem Thromb Hemost 1985; 11: 326-329.
5. Vitoux JF, Mathieu JF, Roncato M, Aiach M, Fiessinger JN. Heparin-associated thrombocytopenia: treatment with low molecular weight heparin (letter). Thromb Haemost 1990; 55: 37.
6. Horellou MH, Conard J, Lecrubier C, et al. Persistent heparin induced thrombocytopenia despite therapy with low molecular weight heparin (letter). Thromb Haemost 1984; 51: 134.
7. Eichinger S, Kyrle PA, Brenner B, et al. Thrombocytopenia associated with low-molecular-weight heparin (letter). Lancet 1991; 337: 1425.
8. Lecompte T, Luo SK, Stieltjes N, Lecrubier C, Samama MM. Thrombocytopenia associated with low molecular weight heparin (letter). Lancet 1991, 338: 1217.
9. Warkentin TE, Levine MN, Roberts RS, Gent M, Horsewood P, Kelton JG. Heparin-induced thrombocytopenia is more common with unfractionated heparin than with low molecular weight heparin (letter). Thromb Haemost 1993; 69: 911.
10. Greinacher A, Amiral J, Dummel V, Vissac V, Kiefel V, Mueller-Eckardt C. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation, heparin-induced platelet activation, and platelet-factor4/heparin enzyme-linked immunosorbent assay. Transfusion 1994; 34: 381-385.
11. Amiral J, Bridey F, Dreyfus M, et al. Platelet-factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68: 95-96.
12. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335.
13. Hach-Wunderle V, Kainer K, Salzmann G, Müller-Berghaus G, Pötzsch B. Heparin-associated thrombosis despite normal platelets count. Ann Hematol 1995; 70: A56 (abstract).
14. Bara I., Cadieu G, Samama MM. Absence of relationship between anti-Xa and anti-Ha D dimers and clinical event in a randomized double blind trial comparing tinzaparin versus enoxaparin in a total hip replacement. 15th congress of the ISTH. Thromb Haemost 1995; 73: 1632 (abstract).
15. Fratantoni JC, Pollet R, Gralnick HR. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood 1975; 45: 395-399.
16. Lecrubier C, Lecompte T, Potevin F, Horellou MH, Conard J, Samama MM. Heparin-induced thrombocytopenia: methodological and diagnostic problems and therapeutic aspects (a study of 26 cases). J Mal Vasc 1987; 12: 128-132.
17. Souied F, Pourriat JL, Leroux G, et al. Adrenal hemorrhagic necrosis related to heparin-associated thrombocytopenia. Crit Care Med 1991; 19: 297-299.
18. Cathebras P, Cuilleron M, Favre JP, Bouchou K, Rousset H. Infarctus hémorragiques des surrénales au cours d'une thrombopénie à l'héparine (letter). Presse Méd 1994; 23: 1311.
19. Leschi JP, Goëau-Brissonnière O, Coggia M, Chiche L. Nécrose des surrénales et thrombopénie à l'héparine après chirurgie aortique. Ann Chir Vasc 1994; 8: 506-508.
20. Eichinger S, Kyrle P, Breuner B, et al. Thrombocytopenia associated with low-molecular-weight heparin (letter). Lancet 1991; 337: 1425-1426.
21. Recommandations du GEHT sur l'utilisation des traitements antithrombotiques (héparines) en pratique médicale courante. Sang Thrombose Vaisseaux 1991; 3: 4-10.
22. Gruel Y, Boizard-Boval B, Wautier JL. Further evidence that alpha-granule components such as platelet factor 4 are involved in platelet-IgG-heparin interactions during heparin-associated thrombocytopenia (letter). Thromb Haemost 1993; 70: 374.
23. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81-88.
24. McDonald KH III, Brenda RA. Importance of PF4 in heparin-induced thrombocytopenia: confirmation with gray platelets (letter). Blood 1995; 85: 1408-1409.
25. Greinacher A, Michels I, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: the antibody is not heparin specific. Thromb Haemost 1992; 67: 545-549.
26. Adams JG, Humphrey LJ, Zhang X, Silver D. Do patients with heparin-induced thrombocytopenia syndrome have heparin-specific antibodies? J Vasc Surg 1995; 21: 247-254.
27. Greinacher A, Michels I, Liebenhoff U, Presek P, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: immunes complexes are attached to platelet membrane by the negative charge of highly sulfated oligosaccharides. Br J Haematol 1993; 84: 711-716.
28. Hirsh J, Raschke R, Warkentin TE, Dalen JE, Deykin D, Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995; 108: 258S-275S.
29. Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30.
30. Greinacher A, Michels I, Kiefel V, Mueller-Eckhardt C. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991; 66: 734-736.
31. Arepally G, Reynolds C, Tomaski A, Amiral J, Jawad A, Poncz M, Cines DB. Comparison of PF4/heparin ELISA assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Path 1995; 104: 648-654.
32. Cadroy Y, Amiral J, Raynaud H, Brunel P, Mazaleyrat A, Sauer M, Sie P. Evolution of antibodies anti-PF4/heparin in a patient with a history of heparin-induced thrombocytopenia re-exposed to heparin (letter). Thromb Haemost 1994; 72: 783-784.